FGF23/FGFR4-mediated left ventricular hypertrophy is reversible. - sprookjes - yvandenbroek - TriplyDB

FGF23/FGFR4-mediated left ventricular hypertrophy is reversible.

FGF23/FGFR4-mediated left ventricular hypertrophy is reversible.

http://www.wikidata.org/entity/Q33694566

about

FGF23 Actions on Target Tissues-With and Without Klotho.High Fibroblast Growth Factor 23 concentrations in experimental renal failure impair calcium handling in cardiomyocytes.Impact of Altered Mineral Metabolism on Pathological Cardiac Remodeling in Elevated Fibroblast Growth Factor 23.Cardiotoxicity of Uremic Toxins: A Driver of Cardiorenal Syndrome

P2860

Q54960612-96C87CCA-532A-4404-9AD8-3C055997C2D9 Q55399715-2F6D5FCC-E37F-4D47-910B-89F6CD9432CA Q55413743-BD99F4F8-90DE-4944-873C-5F5B03CA4E60 Q58773641-E1075203-A0BF-47C1-8D17-8BF546044D32

P2860

FGF23/FGFR4-mediated left ventricular hypertrophy is reversible.

http://www.wikidata.org/entity/Q33694566

description

2017 nî lūn-bûn

@nan

2017 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

FGF23/FGFR4-mediated left ventricular hypertrophy is reversible.

@ast

FGF23/FGFR4-mediated left ventricular hypertrophy is reversible.

@en

type

label

FGF23/FGFR4-mediated left ventricular hypertrophy is reversible.

@ast

FGF23/FGFR4-mediated left ventricular hypertrophy is reversible.

@en

prefLabel

FGF23/FGFR4-mediated left ventricular hypertrophy is reversible.

@ast

FGF23/FGFR4-mediated left ventricular hypertrophy is reversible.

@en

P1433

Q33694566-AF80BE6D-17B1-42CF-9E30-7C172CE4CBE0

P1476

Q33694566-A1D3D1A6-0E1F-42BF-87F3-693FB298811A

P2093

Q33694566-18E5967A-737A-42E3-B588-33B64B98E59A

Q33694566-39D9A4BA-B13E-491F-9DFC-2D6B6EF33445

Q33694566-3EE4A9A8-9C59-4358-850C-0C55C3B7C007

Q33694566-4DDA75B4-72E5-49DD-BF81-A9C08ED068FF

Q33694566-66DBB7F4-39AB-45C9-8CB3-12E124BAD1A7

Q33694566-7D20EE0A-66F6-414B-BD94-8D57E89248D1

Q33694566-83F4A2BC-6B29-45A0-8110-0BD8D8C3B48C

Q33694566-98FF8CCA-789C-4FE5-AF51-59E79427B3E2

Q33694566-E3456712-00CE-480A-99E8-E0D7C429DE55

Q33694566-FA8B6754-1617-43C5-B3A5-1A6878521D3F

P2860

Q33694566-07FFBFE6-5EBE-483F-BD5B-7E24004C9A36

Q33694566-28B36557-405C-464F-B1E2-0EDC55AAA14C

Q33694566-2EBC2793-9FC8-40EA-B491-B78100444613

Q33694566-392AA1BF-A53E-4B09-8CC0-0A331D45D298

Q33694566-3B11A88D-DBFE-4F87-9C4B-418EBCC24C65

Q33694566-3C525046-F2FA-438F-8432-D896FEA0349D

Q33694566-3FD5A9DE-43F5-4091-A265-83DEC6D835D8

Q33694566-5F3C5E4B-380B-4955-A83C-7F901AE998D4

Q33694566-60737CF0-FA85-44B0-8344-25486D1E57E9

Q33694566-63F7AA04-DBE5-4F75-9ED8-FC75971B5C37

P2888

Q33694566-DD4EC51B-A035-4858-9B8B-6DB2C52BEC77

P304

Q33694566-6E1272B4-0DD8-447E-8C2E-3E008D490613

P31

Q33694566-97DEC9C8-8F3C-4696-AC83-92DF247DBB6B

P356

Q33694566-366C214A-27BA-4F06-B27F-AB9D6A764C71

P407

Q33694566-AD7D5D3A-8F55-41CE-8428-A119D54FA185

P433

Q33694566-0A48FC5A-7160-48E4-A275-3F524F0CCDD0

P478

Q33694566-A829A333-33B6-4C14-A4C2-7D5C3D59F656

P50

Q33694566-5604EC68-6A58-42BA-A894-5D0DD07BC45C

Q33694566-CB6A1231-6F16-4CAD-B3E7-246C97E26AC0

Q33694566-D7799FE1-34DA-4695-8C02-F31AF4105536

Q33694566-DB55AFA6-E58F-4FE8-9DE7-1573B75DA0C0

P577

Q33694566-F5D37D00-4D62-42B5-87DD-519D1C1BFF37

P6179

Q33694566-7887A691-F659-4A6C-B9B1-D925CD8A77D0

P698

Q33694566-E9BEE445-2B00-4818-BC28-48F5A886E7AB

P932

Q33694566-7932E00C-7E5A-45AB-B4FD-19D84915C1DC

P356

S41598-017-02068-6

P1433

Scientific Reports

P1476

FGF23/FGFR4-mediated left ventricular hypertrophy is reversible.

@en

P2093

Brian Czaya

http://www.w3.org/2001/XMLSchema#string

Christian Faul

http://www.w3.org/2001/XMLSchema#string

Christopher Yanucil

http://www.w3.org/2001/XMLSchema#string

Giovana Seno Di Marco

http://www.w3.org/2001/XMLSchema#string

Jörg Stypmann

http://www.w3.org/2001/XMLSchema#string

Karla Schramm

http://www.w3.org/2001/XMLSchema#string

Marcus Brand

http://www.w3.org/2001/XMLSchema#string

Matt Hendrix

http://www.w3.org/2001/XMLSchema#string

Saurav Singh

http://www.w3.org/2001/XMLSchema#string

Sven Hermann

http://www.w3.org/2001/XMLSchema#string

P2860

The FGF23-Klotho axis: endocrine regulation of phosphate homeostasis

Fibroblast growth factor receptor 1 signaling in adult cardiomyocytes increases contractility and results in a hypertrophic cardiomyopathy

Regulation of renal phosphate transport by FGF23 is mediated by FGFR1 and FGFR4

Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis

Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease.

Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population.

The associations of fibroblast growth factor 23 and uncarboxylated matrix Gla protein with mortality in coronary artery disease: the Heart and Soul Study.

FGF23 induces left ventricular hypertrophy

FGF23 is a novel regulator of intracellular calcium and cardiac contractility in addition to cardiac hypertrophy.

FGF23 directly impairs endothelium-dependent vasorelaxation by increasing superoxide levels and reducing nitric oxide bioavailability.

P2888

s41598-017-02068-6

P304

1993

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41598-017-02068-6

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Neerupma Silswal

Alexander Grabner

Michael J Wacker

P577

2017-05-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1085379422

http://www.w3.org/2001/XMLSchema#string

P698

28512310

http://www.w3.org/2001/XMLSchema#string

P932

5434018

http://www.w3.org/2001/XMLSchema#string